Oral glycopyrrolate for the treatment of chronic severe drooling caused by neurological disorders in children

Overview of attention for article published in Neuropsychiatric Disease and Treatment, September 2011

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 36 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide

Cited by National Institute for Health and Care Excellence on 14 Feb 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.